Sunday, September 20, 2026
29.3 C
Bengaluru

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in early August 2026, Minister of State for Health Prataprao Jadhav stated that the Indian Council of Medical Research (ICMR) has not conducted any study to assess whether ultra-processed foods (UPFs) exhibit addiction-like behavioural characteristics comparable to tobacco products or other habit-forming substances.

At the same time, the Minister noted that, based on available global scientific evidence, ICMR has indicated that higher consumption of UPFs is associated with an increased risk of adverse health outcomes, including obesity, type 2 diabetes, cardiovascular diseases and mental disorders. These conditions are multifactorial in origin, and high UPF intake is considered one of several modifiable risk factors. The available evidence is largely observational and does not, by itself, establish causality.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Topics

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...
spot_img

Related Articles

spot_imgspot_img